Inhibitor Therapeutics, Inc. INTI
Set alert
0.10 USD +0.03 +49.23%
At close · Oct 30
0.0611 Day range 0.0611
0.04 52-week range 0.124
- YTD
- +115.56%
- 1 year
- +94.00%
- Open
- 0.0611
- Prev close
- 0.065
- Mkt cap
- 16.95M
- Vol
- 90.00K
- Avg vol
- 9.15K
- EPS
- -0.02
- P/E
- 0.00
More statistics
- Low
- 0.0611
- High
- 0.0611
3M chart
Signals (35)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 12, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 1 month ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 12, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 11, 2026 | 2 months ago |
| SMA: Bearish | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| RSI: Oversold | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
News
- Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting
- Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome
- Complement Inhibitor Therapeutics Pipeline Developments Research Report 2024
- Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight
- Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan
- 3 Intriguing Stocks to Watch as Earnings Approach
- Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board
Your note
Sign in to keep a note on INTI — it syncs with the Stock Master app.